Cue Biopharma, Inc.

SecurityCUE / Cue Biopharma, Inc.
InstitutionStifel Financial Corp
Latest Disclosed Ownership246,556 shares
Latest Disclosed Value $ 56,683
Stifel Financial Corp ownership in CUE / Cue Biopharma, Inc.

On May 12, 2026 - Stifel Financial Corp filed a 13F-HR form disclosing ownership of 246,556 shares of Cue Biopharma, Inc. (US:CUE) valued at $56,683 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 246,556 shares of Cue Biopharma, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $6,634,822 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F CUE BIOPHARMA COM 22978P106 246,556 0 0.00 57 -25.33 0.0001
2026-02-13 2025-12-31 13F CUE BIOPHARMA COM 22978P106 246,556 50,000 25.44 75 -46.81 0.0001
2025-11-12 2025-09-30 13F CUE BIOPHARMA COM 22978P106 196,556 0 0.00 141 5.22 0.0001
2025-08-14 2025-06-30 13F CUE BIOPHARMA COM 22978P106 196,556 -7,022 -3.45 134 -27.57 0.0001
2025-05-14 2025-03-31 13F CUE BIOPHARMA COM 22978P106 203,578 -7,783 -3.68 185 -19.57 0.0002
2025-02-13 2024-12-31 13F CUE BIOPHARMA COM 22978P106 211,361 17,139 8.82 230 56.46 0.0002
2024-11-14 2024-09-30 13F CUE BIOPHARMA COM 22978P106 194,222 232 0.12 147 -38.75 0.0002
2024-08-13 2024-06-30 13F CUE BIOPHARMA COM 22978P106 193,990 1,398 0.73 241 -34.07 0.0003
2024-05-14 2024-03-31 13F CUE BIOPHARMA COM 22978P106 192,592 -1,383 -0.71 364 -28.91 0.0004
2024-02-12 2023-12-31 13F CUE BIOPHARMA COM 22978P106 193,975 46,763 31.77 512 51.48 0.0006
2023-11-13 2023-09-30 13F CUE BIOPHARMA COM 22978P106 147,212 -109 -0.07 339 -37.06 0.0005
2023-08-14 2023-06-30 13F CUE BIOPHARMA COM 22978P106 147,321 857 0.59 538 2.87 0.0007
2023-05-12 2023-03-31 13F CUE BIOPHARMA COM 22978P106 146,464 16,101 12.35 523 40.70 0.0007
2023-02-13 2022-12-31 13F CUE BIOPHARMA COM 22978P106 130,363 63,707 95.58 372 150.68 0.0006
2022-11-14 2022-09-30 13F CUE BIOPHARMA COM 22978P106 66,656 0 0.00 148 -10.30 0.0002
2022-08-15 2022-06-30 13F CUE BIOPHARMA COM 22978P106 66,656 0 0.00 165 -49.23 0.0003
2022-05-13 2022-03-31 13F CUE BIOPHARMA COM 22978P106 66,656 0 0.00 325 -56.90 0.0004
2022-02-14 2021-12-31 13F CUE BIOPHARMA COM 22978P106 66,656 770 1.17 754 -21.46 0.0010
2021-11-15 2021-09-30 13F CUE BIOPHARMA COM 22978P106 65,886 0 0.00 960 25.00 0.0014
2021-08-13 2021-06-30 13F CUE BIOPHARMA COM 22978P106 65,886 0 0.00 768 -4.48 0.0011
2021-05-14 2021-03-31 13F CUE BIOPHARMA COM 22978P106 65,886 0 0.00 804 -2.43 0.0013
2021-02-12 2020-12-31 13F CUE BIOPHARMA COM 22978P106 65,886 0 0.00 824 -16.85 0.0015
2020-11-16 2020-09-30 13F CUE BIOPHARMA COM 22978P106 65,886 0 0.00 991 -38.64 0.0020
2020-08-14 2020-06-30 13F CUE BIOPHARMA COM 22978P106 65,886 10,031 17.96 1,615 103.91 0.0037
2020-05-14 2020-03-31 13F CUE BIOPHARMA COM 22978P106 55,855 0 0.00 792 -10.71 0.0022
2020-02-13 2019-12-31 13F CUE BIOPHARMA COM 22978P106 55,855 0 0.00 887 88.32 0.0018
2019-11-19 2019-09-30 13F/A-1 CUE BIOPHARMA COM 22978P106 55,855 0 0.00 471 -6.18 0.0012
2019-11-13 2019-09-30 13F CUE BIOPHARMA COM 22978P106 55,855 0 471 264.0191
2019-08-14 2019-06-30 13F CUE BIOPHARMA COM 22978P106 55,855 55,855 502 0.0013
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.